Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa

Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.

Guardado en:
Detalles Bibliográficos
Autores principales: Harry O. Orlans, Michelle E. McClements, Alun R. Barnard, Cristina Martinez-Fernandez de la Camara, Robert E. MacLaren
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f079a2227d8741e1858d4c8fe8a57b28
record_format dspace
spelling oai:doaj.org-article:f079a2227d8741e1858d4c8fe8a57b282021-12-02T18:01:12ZMirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa10.1038/s41467-021-25204-32041-1723https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b282021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25204-3https://doaj.org/toc/2041-1723Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.Harry O. OrlansMichelle E. McClementsAlun R. BarnardCristina Martinez-Fernandez de la CamaraRobert E. MacLarenNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Harry O. Orlans
Michelle E. McClements
Alun R. Barnard
Cristina Martinez-Fernandez de la Camara
Robert E. MacLaren
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
description Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.
format article
author Harry O. Orlans
Michelle E. McClements
Alun R. Barnard
Cristina Martinez-Fernandez de la Camara
Robert E. MacLaren
author_facet Harry O. Orlans
Michelle E. McClements
Alun R. Barnard
Cristina Martinez-Fernandez de la Camara
Robert E. MacLaren
author_sort Harry O. Orlans
title Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
title_short Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
title_full Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
title_fullStr Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
title_full_unstemmed Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
title_sort mirtron-mediated rna knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f079a2227d8741e1858d4c8fe8a57b28
work_keys_str_mv AT harryoorlans mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa
AT michelleemcclements mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa
AT alunrbarnard mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa
AT cristinamartinezfernandezdelacamara mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa
AT robertemaclaren mirtronmediatedrnaknockdownreplacementtherapyforthetreatmentofdominantretinitispigmentosa
_version_ 1718379023467282432